Graphium biosciences inc
Web4.4K 52-Wk Range 0.1201 - 0.2986 (04/28/22 - 10/11/22) 33.22% Historical Volatility 149.3% Market Cap 12.5M Shares Outstanding 78.1M EPS (TTM, GAAP) -0.03 P/E Ratio (TTM, GAAP) -- Annual Dividend/Yield No dividend Ex-dividend Date No dividend Dividend Pay Date No dividend Beta 2.6 % Held by Institutions 0.10 Short Interest -- WebDec 28, 2024 · Graphium Biosciences, our operating subsidiary dedicated to improving the health and wellness of people, seeks to advance our broad portfolio of over 100 novel …
Graphium biosciences inc
Did you know?
WebSince we were founded in 1989, we've focused on providing innovative solutions for education and business. Get in touch. 45190 Prologis Plaza, Suite 165. Dulles , VA … WebMar 8, 2024 · Its Graphium Biosciences, Inc. is focused on advancing its portfolio of over 100 cannabinoid-glycoside compounds created using its enzymatic bioprocessing technologies to develop treatments for chronic and debilitating conditions. Daedalus Ecosciences, Inc. (Daedalus). is focused on the health and wellness through …
WebDec 28, 2024 · Graphium Biosciences, our operating subsidiary dedicated to improving the health and wellness of people, seeks to advance our broad portfolio of over 100 novel … WebGraphium Biosciences, Inc. is a cannabinoid-based drug development company tracing its history of technological innovation and drug advancement back to October 2011 through two predecessor ...
WebMar 30, 2024 · About MLCT. Malachite Innovations, Inc., together with its subsidiaries, provides health and wellness products in the United States. It offers a portfolio of approximately 100 novel cannabosides, including glycosylated tetrahydrocannabinol, cannabidiol, cannabidivarin, and cannabinol. The company also develops THC-glycoside … WebApr 5, 2024 · Graphium Biosciences, Inc. (“Graphium”) is a cannabinoid-based drug development company tracing its history of technological innovation and drug …
WebOct 12, 2024 · Graphium Biosciences, our operating subsidiary dedicated to improving the health and wellness of people, seeks to advance our broad portfolio of over 100 novel cannabinoid-glycoside compounds created using our proprietary enzymatic bioprocessing technologies to develop safe and effective novel treatments for chronic and debilitating …
WebDec 28, 2024 · Graphium Biosciences, our operating subsidiary dedicated to improving the health and wellness of people, seeks to advance our broad portfolio of over 100 novel … shank chiropracticWebApr 5, 2024 · Graphium Biosciences, Inc. ("Graphium") is a cannabinoid-based drug development company tracing its history of technological innovation and drug … shank chip shotWebApr 6, 2024 · Malachite Innovations, Inc. FY 2024 revenue was $4.8 million compared to $0 of revenue reported for the four calendar yea... Malachite Innovations FY22 Revenue Grows To $4.8M, Achieving More Than Its Total Revenue Over Its Previous 10 Years Of … polymer coatings and epoxy supplyWebMay 13, 2024 · We now have the requisite capital to further advance our ESG-centric mission of creating a market-leading environmental services business that improves the health and wellness of our planet, with a... polymer coating for sublimation printingWebAug 19, 2024 · Malachite Innovations, Inc. is a holding company. The Company is engaged in improving the health and wellness of people. The Company operates through its subsidiaries Graphium Biosciences, Inc. and Daedalus Ecosciences, Inc. Graphium Biosciences, Inc. focused its business activities on the health and wellness of people, … shank charcuterieWebMar 27, 2024 · VITALITY BIOPHARMA INC. Malachite Innovations, Inc. is a holding company, which operates through its subsidiaries Graphium Biosciences, Inc. and Daedalus Ecosciences, Inc. The Company focuses on improving the health and wellness of people and the planet. Its segments include Therapeutic Operations and ESG Operations. polymer coated slow release fertilizerWebMar 31, 2024 · Its Graphium Biosciences, Inc. is focused on advancing its portfolio of over 100 cannabinoid-glycoside compounds created using its enzymatic bioprocessing technologies to develop treatments for chronic and debilitating conditions. Daedalus Ecosciences, Inc. (Daedalus). is focused on the health and wellness through … polymer coatings